BioStem Technologies, Inc. (BSEM)
Last updated: 2026-10-21 22:58:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
BioStem Technologies, Inc. (BSEM) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.65, with a market capitalization of $28.76M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.45 to $8.40. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$28.76M | |
$1.62 | |
$28.26 | |
$0.80 | |
$1.64 | |
196.58K | |
136.61K | |
-- | |
$8.40 | |
$1.45 | |
-- | |
-- |
BioStem Technologies, Inc. (BSEM) After-Hours Stock Price
BioStem Technologies, Inc. (BSEM) is trading at $1.68 in after-hours trading as of 2026-10-21 22:57:00, up 2.44% ($0.04) from the regular-session close of $1.64.
After-hours trading shows how investors are pricing BSEM after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
BioStem Technologies, Inc. (BSEM) 7-Day Stock Price Change
Over the past seven days, BioStem Technologies, Inc. (BSEM) moved from $2.44 to $1.65, representing a decline of 32.38% ($0.79).
The stock traded between $1.45 and $2.50 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 131.92 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
BSEM 52-Week Price Position
Position in Range: 2.9%
BSEM is currently trading at $1.65, placing it 2.9% of the way from its 52-week low of $1.45 to its 52-week high of $8.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is BioStem Technologies, Inc. (BSEM)?
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
BioStem Technologies, Inc. Information
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy BioStem Technologies, Inc. (BSEM) Stock on MEXC
Eligible investors can buy real shares of BioStem Technologies, Inc. (BSEM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is BioStem Technologies, Inc. (BSEM) stock price today?
2.Is BSEM stock going up or down today?
3.What is BSEM pre-market price?
4.What is BSEM after-hours price?
5.Is BSEM stock trading now?
6.Where does BSEM sit relative to its 52-week high and low?
7.What sector is BioStem Technologies, Inc. in?
8.What is BioStem Technologies, Inc.'s market capitalization and where is it listed?
9.How is BSEM valued in terms of P/E ratio and EPS?
10.Does BioStem Technologies, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BSEM Stock Calculator
Estimate the value between BSEM shares and USD.
BSEM Shares to USD
1.00 BSEM shares = 1.65 USD
Calculations are estimates based on the latest available price and are for reference only.


